Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Sangoma Technologies Corporation | 54GA | Nov 25, 2024 | 5.75 | +1.77 |
Saniona | 30S | Nov 25, 2024 | 0.22 | +4.95 |
Sanken Electric Co. Ltd. | XSK | Nov 25, 2024 | 36.00 | +5.26 |
Sankyo Co | SOK | Nov 25, 2024 | 12.90 | -1.53 |
Sankyu Inc. | SNK | Nov 25, 2024 | 32.20 | +0.63 |
Sanlam | LA6S | Nov 25, 2024 | 9.30 | +0.54 |
Sanlam | LA6A | Nov 25, 2024 | 4.72 | +0.85 |
Sanlorenzo S.p.a. | 6SZA | Nov 25, 2024 | 30.50 | +1.16 |
Sanmina Corporation | SAYN | Nov 25, 2024 | 74.80 | -1.32 |
Sanofi | SNW | Nov 25, 2024 | 92.73 | +0.25 |
Sanofi - American Depositary Shares | SNW2 | Nov 25, 2024 | 46.40 | +0.87 |
Sanok Rubber Company SA | 1NX | Nov 25, 2024 | 4.34 | +1.05 |
Sanoma | SNQB | Nov 25, 2024 | 7.01 | +0.72 |
Sanrio Company Ltd. | SJ8 | Nov 25, 2024 | 30.60 | +2.68 |
Santacruz Silver Mining Ltd | 1SZ | Nov 25, 2024 | 0.19 | -2.65 |
Santander Bank Polska S. A. | BZI | Nov 25, 2024 | 101.30 | -0.69 |
Santen Pharmaceutical Co. Ltd. | SZD | Nov 25, 2024 | 10.50 | +3.96 |
Santorius AG Unsponsored ADR (Germany) | SRT4 | Nov 25, 2024 | 34.20 | +6.88 |
Santos Ltd | STS1 | Nov 25, 2024 | 4.18 | -0.50 |
Sanu Gold Corp | L73 | Nov 25, 2024 | 0.02 | +19.44 |
Sanwa Holdings Corp. | XST | Nov 25, 2024 | 27.60 | -0.72 |
SANY INTL | YXS | Nov 25, 2024 | 0.60 | +4.29 |
Sanyo Chemical Industries Ltd. | XSI | Nov 25, 2024 | 24.20 | 0.00 |
SAP SE ADS | SAPA | Nov 25, 2024 | 222.00 | -0.89 |
Sap SE | SAP | Nov 25, 2024 | 223.20 | -1.28 |
Sapiens International Corporation N.V. - | S3P | Nov 25, 2024 | 27.00 | +3.05 |
Sappi Ltd | SPI | Nov 25, 2024 | 2.68 | +3.08 |
Sappi Ltd | SPIA | Nov 25, 2024 | 2.58 | +4.03 |
Sapporo Holdings Ltd. | SBW | Nov 25, 2024 | 51.50 | -0.96 |
Saputo Inc | SB7 | Nov 25, 2024 | 17.90 | -0.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.